aPAP ClearPath Blood Test Helps Physicians Diagnose Autoimmune Pulmonary Alveolar Proteinosis
In December 2023, clinical-stage biopharmaceutical company Savara Inc. announced that the company had launched a serum-based blood test to aid in diagnosing autoimmune pulmonary alveolar proteinosis (aPAP). While aPAP is…